New options may improve accuracy of risk adjustment.
While the ability to risk-adjust payments is increasingly important to provider groups and health plans, diagnosis data that have been found to be the best predictors often are not readily available. But help may be on the way in the form of predictive programs that use either pharmacy data alone or pharmacy data in combination with inpatient data.